Cefazedone
Chemical compound
- J01DB06 (WHO)
- (6R,7R)-7-{[2-(3,5-dichloro-4-oxopyridin-1-yl)
acetyl]amino}-3-[(5-methyl-1,3,4-thiadiazol-2-yl)
sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]
oct-2-ene-2-carboxylic acid
- 56187-47-4
- 71736
- 64780 Y
- 7Y86X0D799
- D07237 Y
- CHEBI:131731
- ChEMBL2107636
- DTXSID50204733
- Interactive image
- O=C2N1/C(=C(\CS[C@@H]1[C@@H]2NC(=O)CN/3/C=C(/Cl)C(=O)C(\Cl)=C\3)CSc4nnc(s4)C)C(=O)O
InChI
- InChI=1S/C18H15Cl2N5O5S3/c1-7-22-23-18(33-7)32-6-8-5-31-16-12(15(28)25(16)13(8)17(29)30)21-11(26)4-24-2-9(19)14(27)10(20)3-24/h2-3,12,16H,4-6H2,1H3,(H,21,26)(H,29,30)/t12-,16-/m1/s1 Y
- Key:VTLCNEGVSVJLDN-MLGOLLRUSA-N Y
Cefazedone is a cephalosporin antibiotic.[1]
References
- ^ Wahlig H, Dingeldein E, Mitsuhashi S, Kawabe H (1979). "Cefazedone: microbiological evaluation in comparison with cephalothin and cefazolin". Arzneimittel-Forschung. 29 (2a): 369–78. PMID 582712.
External links
- Cefazedone Information
- v
- t
- e
(inhibit synthesis
of peptidoglycan
layer of bacterial
cell wall by binding
to and inhibiting
PBPs, a group of
D-alanyl-D-alanine
transpeptidases)
Lipopeptides |
|
---|---|
Other |
|
- Inhibit PG subunit synthesis and transport: NAM synthesis inhibition (Fosfomycin)
- DADAL/AR inhibitors (Cycloserine)
- bactoprenol inhibitors (Bacitracin)
- Hydrolyze NAM-NAG
- Tyrothricin
- Isoniazid#
- Teixobactin
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
This systemic antibiotic-related article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e